PRA Health Sciences Inc (NASDAQ:PRAH) Shares Sold by Strs Ohio

Strs Ohio trimmed its holdings in shares of PRA Health Sciences Inc (NASDAQ:PRAH) by 0.4% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 292,396 shares of the medical research company’s stock after selling 1,223 shares during the quarter. Strs Ohio’s holdings in PRA Health Sciences were worth $28,991,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in PRAH. Norges Bank purchased a new position in shares of PRA Health Sciences during the 4th quarter valued at approximately $53,228,000. FMR LLC increased its holdings in PRA Health Sciences by 11.3% in the 1st quarter. FMR LLC now owns 2,881,740 shares of the medical research company’s stock worth $317,827,000 after acquiring an additional 292,887 shares in the last quarter. Virginia Retirement Systems ET AL increased its holdings in PRA Health Sciences by 934.2% in the 1st quarter. Virginia Retirement Systems ET AL now owns 166,500 shares of the medical research company’s stock worth $18,363,000 after acquiring an additional 150,400 shares in the last quarter. Geode Capital Management LLC increased its holdings in PRA Health Sciences by 16.9% in the 4th quarter. Geode Capital Management LLC now owns 641,658 shares of the medical research company’s stock worth $59,006,000 after acquiring an additional 92,838 shares in the last quarter. Finally, Retirement Systems of Alabama increased its holdings in PRA Health Sciences by 103.8% in the 1st quarter. Retirement Systems of Alabama now owns 154,476 shares of the medical research company’s stock worth $17,037,000 after acquiring an additional 78,662 shares in the last quarter. Institutional investors and hedge funds own 99.84% of the company’s stock.

PRAH traded down $0.48 on Wednesday, hitting $97.42. 199,508 shares of the company’s stock were exchanged, compared to its average volume of 545,498. PRA Health Sciences Inc has a fifty-two week low of $82.12 and a fifty-two week high of $121.98. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.99 and a current ratio of 0.99. The firm’s 50-day simple moving average is $98.54. The company has a market capitalization of $6.43 billion, a PE ratio of 24.79, a price-to-earnings-growth ratio of 1.31 and a beta of 1.12.

PRA Health Sciences (NASDAQ:PRAH) last announced its earnings results on Wednesday, July 31st. The medical research company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.11. PRA Health Sciences had a net margin of 5.39% and a return on equity of 26.64%. The company had revenue of $763.31 million for the quarter, compared to analysts’ expectations of $764.95 million. During the same quarter in the previous year, the company posted $1.00 EPS. The firm’s quarterly revenue was up 5.6% on a year-over-year basis. As a group, equities research analysts forecast that PRA Health Sciences Inc will post 4.61 EPS for the current fiscal year.

Several equities research analysts recently commented on PRAH shares. Svb Leerink reissued a “market perform” rating on shares of PRA Health Sciences in a report on Tuesday, July 2nd. Mizuho set a $100.00 price target on shares of PRA Health Sciences and gave the stock a “hold” rating in a report on Friday, May 3rd. ValuEngine lowered shares of PRA Health Sciences from a “buy” rating to a “hold” rating in a report on Saturday, April 13th. Leerink Swann started coverage on shares of PRA Health Sciences in a report on Tuesday, July 2nd. They issued a “market perform” rating and a $105.00 price target for the company. Finally, BidaskClub raised shares of PRA Health Sciences from a “hold” rating to a “buy” rating in a report on Wednesday, July 24th. Eight equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $113.40.

About PRA Health Sciences

PRA Health Sciences, Inc, a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services.

Read More: What does an equal weight rating mean?

Want to see what other hedge funds are holding PRAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PRA Health Sciences Inc (NASDAQ:PRAH).

Institutional Ownership by Quarter for PRA Health Sciences (NASDAQ:PRAH)

Receive News & Ratings for PRA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PRA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.